Genetic association of adiponectin with type 2 diabetes in Jordanian Arab population

Gene

Volumn 512, Issue 1, 2013, Pages 61-63

  Alkhateeb, Asem ^a   Al Azzam, Sayer ^a   Zyadine, Raya ^a   Abuarqoub, Duaa ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Adiponectin; Association; Diabetes; Polymorphism

Indexed keywords

ADIPONECTIN; DNA;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIABETIC PATIENT; DNA EXTRACTION; GENETIC ASSOCIATION; HUMAN; JORDAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SAMPLING;

ADIPONECTIN; ALLELES; ARABS; DIABETES MELLITUS, TYPE 2; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; JORDAN;

EID: 84868615675     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.09.095     Document Type: Article

References (34)

1. Ajlouni K., Khader Y., Batieha A., Ajlouni H., El-Khateeb M. An increase in prevalence of diabetes mellitus in Jordan over 10years. J. Diabetes Complications 2008, 22:317-324.
2. Al-Daghri N.M., et al. Adiponectin gene polymorphisms (T45G and G276T), adiponectin levels and risk for metabolic diseases in an Arab population. Gene 2012, 493(1):142-147.
3. American Diabetes Association National Diabetes Fact Sheet, Alexandria, VA, ADA Available at:, Accessed April 15, 2012. http://www.diabetes.org.
4. Bevan S., Meidtner K., Lorenz M., Sitzer M., Grant P.J., Markus H.S. Adiponectin level as a consequence of genetic variation, but not leptin level or leptin: adiponectin ratio, is a risk factor for carotid intima-media thickness. Stroke 2011, 42(6):1510-1514.
5. Chiodini B.D., et al. Adiponectin gene polymorphisms and their effect on the risk of myocardial infarction and type 2 diabetes: an association study in an Italian population. Ther. Adv. Cardiovasc. Dis. 2010, 4:223-230.
6. Gable D.R., et al. Common adiponectin gene variants show different effects on risk of cardiovascular disease and type 2 diabetes in European subjects. Ann. Hum. Genet. 2007, 71(Pt 4):453-466.
7. Gibson F., Froguel P. Genetics of the APM1 locus and its contribution to type 2 diabetes susceptibility in French Caucasians. Diabetes 2004, 53(11):2977-2983.
8. Gong M., Long J., Liu Q., Deng H.C. Association of the ADIPOQ rs17360539 and rs266729 polymorphisms with type 2 diabetes: a meta-analysis. Mol. Cell. Endocrinol. 2010, 325:78-83.
9. Gu H.F., et al. Single nucleotide polymorphisms in the proximal promoter region of the adiponectin (APM1) gene are associated with type 2 diabetes in Swedish Caucasians. Diabetes 2004, 53(Suppl. 1):S31-S35.
10. Han L.Y., et al. Associations between single-nucleotide polymorphisms (+45T>G, +276G>T, -11377C>G, -11391G>A) of adiponectin gene and type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 2011, 54(9):2303-2314.
11. Hegener H.H., Lee I.M., Cook N.R., Ridker P.M., Zee R.Y. Association of adiponectin gene variations with risk of incident myocardial infarction and ischemic stroke: a nested case-control study. Clin. Chem. 2006, 52:2021-2027.
12. Hivert M.F., et al. Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study. Diabetes 2008, 57(12):3353-3359.
13. Kaklamani V.G., et al. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA 2008, 300(13):1523-1531.
14. Kondo H., et al. Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes 2002, 51(7):2325-2328.
15. Lang H.F., Chou C.Y., Sheu W.H., Lin J.Y. Weight loss increased serum adiponectin but decreased lipid levels in obese subjects whose body mass index was lower than 30kg/m2. Nutr. Res. 2011, 31:378-386.
16. Laumen H., et al. Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data. Diabetes 2009, 58(4):984-991.
17. Medina-Bravo P., et al. Decrease in serum adiponectin levels associated with visceral fat accumulation independent of pubertal stage in children and adolescents. Arch. Med. Res. 2011, 42:115-121.
18. Mtiraoui N., Ezzidi I., Turki A., Chaieb A., Mahjoub T., Almawi W.Y. Single-nucleotide polymorphisms and haplotypes in the adiponectin gene contribute to the genetic risk for type 2 diabetes in Tunisian Arabs. Diabetes Res. Clin. Pract. 2012, 97:290-297.
19. Olckers A., Towers G.W., van der Merwe A., Schwarz P.E., Rheeder P., Schutte A.E. Protective effect against type 2 diabetes mellitus identified within the ACDC gene in a black South African diabetic cohort. Metabolism 2007, 56(5):587-592.
20. Pechlivanis S., et al. Genetic variation in adipokine genes and risk of colorectal cancer. Eur. J. Endocrinol. 2009, 160(6):933-940.
21. Prior S.L., Jones D.A., Gill G.V., Bain S.C., Stephens J.W. Association of the adiponectin rs266729 C>G variant and coronary heart disease in the low risk 'Golden Years' type 1 diabetes cohort. Diabetes Res. Clin. Pract. 2011, 91(3):e71-e74.
22. Pyrzak B., Ruminska M., Popko K., Demkow U. Adiponectin as a biomarker of the metabolic syndrome in children and adolescents. Eur. J. Med. Res. 2010, 15(Suppl. 2):147-151.
23. Richards J.B., et al. A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet. 2009, 5(12):e1000768.
24. Schwarz P.E., et al. Global meta-analysis of the C-11377G alteration in the ADIPOQ gene indicates the presence of population-specific effects: challenge for global health initiatives. Pharmacogenomics J. 2009, 9(1):42-48.
25. Siitonen N., et al. Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study. BMC Med. Genet. 2011, 12:5.
26. Szopa M., et al. Variants of the adiponectin gene and type 2 diabetes in a Polish population. Acta Diabetol. 2009, 46(4):317-322.
27. Ukkola O., et al. Adiponectin polymorphisms, adiposity and insulin metabolism: HERITAGE family study and Oulu diabetic study. Ann. Med. 2005, 37(2):141-150.
28. Vasseur F., Lepretre F., Lacquemant C., Froguel P. The genetics of adiponectin. Curr. Diab. Rep. 2003, 3:151-158.
29. Vionnet N., et al. Analysis of 14 candidate genes for diabetic nephropathy on chromosome 3q in European populations: strongest evidence for association with a variant in the promoter region of the adiponectin gene. Diabetes 2006, 55:3166-3174.
30. Wang X., et al. APM1 gene variants -11377C/G and 4545G/C are associated respectively with obesity and with non-obesity in Chinese type 2 diabetes. Diabetes Res. Clin. Pract. 2009, 84(3):205-210.
31. Wassel C.L., Pankow J.S., Jacobs D.R., Steffes M.W., Li N., Schreiner P.J. Variants in the adiponectin gene and serum adiponectin: the Coronary Artery Development in Young Adults (CARDIA) Study. Obesity (Silver Spring) 2010, 18(12):2333-2338.
32. Yamada Y., et al. Association of genetic variants with atherothrombotic cerebral infarction in Japanese individuals with metabolic syndrome. Int. J. Mol. Med. 2008, 21(6):801-808.
33. Yang M., Qiu C.C., Chen W., Xu L.L., Yu M., Xiang H.D. Identification of a regulatory single nucleotide polymorphism in the adiponectin (APM1) gene associated with type 2 diabetes in Han nationality. Biomed. Environ. Sci. 2008, 21(6):454-459.
34. Ziemke F., Mantzoros C.S. Adiponectin in insulin resistance: lessons from translational research. Am. J. Clin. Nutr. 2010, 91(1):258S-261S.